Approval · Notice of Compliance 35024 · 2025
XEOMIN: Notice of Compliance 35024
Issued March 17, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35024
- Date
- March 17, 2025
- Company
- Merz Pharmaceuticals GmbhFrankfurt, Hessen, Germany
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a new strength
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| XEOMIN | Not yet assigned | — |
| XEOMIN | 02556227 | Approved |
Medicinal ingredients
- INCOBOTULINUMTOXINA 50 UNIT per VIAL
- INCOBOTULINUMTOXINA 100 UNIT per VIAL
- INCOBOTULINUMTOXINA 200 UNIT per VIAL